Alexion Pharmaceuticals Inc. v. Canada (Attorney General),

JurisdictionFederal Jurisdiction (Canada)
Neutral Citation2021 FCA 157
Citation2021 FCA 157
CourtCourt of Appeal (Canada)
Date29 July 2021
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
18 practice notes
  • Table of Cases
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...190, 309 Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 ............................................................173, 290, 295, 303, 305 Amgen Canada Inc v Apotex Inc, 2016 FCA 196 ..............................................228 Apotex v Canada (Minister of Hea......
  • Jamali v. Canada (Citizenship and Immigration), 2023 FC 1328
    • Canada
    • Federal Court (Canada)
    • October 5, 2023
    ...render the decision unreasonable: Vavilov, at para 100; Canada Post, at para 33; Alexion Pharmaceuticals Inc v. Canada (Attorney General), 2021 FCA 157, [2022] 1 FCR 153, at para 13. [14] Absent exceptional circumstances, this Court’s role is not to agree or disagree with the decisio......
  • Maarouf v. Canada (Citizenship and Immigration), 2023 FC 787
    • Canada
    • Federal Court (Canada)
    • June 6, 2023
    ...(Justice) v D.V., 2022 FCA 181, at para 17; Safe Food Matters, at paras 50-57; Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 at paras 12 and 43; Canada (Attorney General) v Douglas, 2021 FCA 89, at para 12; Bragg Communications Inc v UNIFOR, 2021 FCA 59, at paras 6 a......
  • Ledshumanan v. Canada (Public Safety and Emergency Preparedness), 2021 FC 1463
    • Canada
    • Federal Court (Canada)
    • December 23, 2021
    ...the “critical point[s]” of the case at hand (Vavilov at para 103; Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 [Alexion] at para 13). The “critical point[s]” of a case are shaped by its central issues, and by the concerns raised by the pa......
  • Request a trial to view additional results
15 cases
  • Jamali v. Canada (Citizenship and Immigration), 2023 FC 1328
    • Canada
    • Federal Court (Canada)
    • October 5, 2023
    ...render the decision unreasonable: Vavilov, at para 100; Canada Post, at para 33; Alexion Pharmaceuticals Inc v. Canada (Attorney General), 2021 FCA 157, [2022] 1 FCR 153, at para 13. [14] Absent exceptional circumstances, this Court’s role is not to agree or disagree with the decisio......
  • Maarouf v. Canada (Citizenship and Immigration), 2023 FC 787
    • Canada
    • Federal Court (Canada)
    • June 6, 2023
    ...(Justice) v D.V., 2022 FCA 181, at para 17; Safe Food Matters, at paras 50-57; Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 at paras 12 and 43; Canada (Attorney General) v Douglas, 2021 FCA 89, at para 12; Bragg Communications Inc v UNIFOR, 2021 FCA 59, at paras 6 a......
  • Ledshumanan v. Canada (Public Safety and Emergency Preparedness), 2021 FC 1463
    • Canada
    • Federal Court (Canada)
    • December 23, 2021
    ...the “critical point[s]” of the case at hand (Vavilov at para 103; Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 [Alexion] at para 13). The “critical point[s]” of a case are shaped by its central issues, and by the concerns raised by the pa......
  • Singh v. Canada (Citizenship and Immigration), 2023 FC 1715
    • Canada
    • Federal Court (Canada)
    • December 18, 2023
    ...administrative regime in which they were given” (Vavilov at paras 97, 103; Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 at para 15). [58] Here, the RAD’s reasons provide a transparent and intelligible justification for the Decision (Vavilov at paras 81......
  • Request a trial to view additional results
3 books & journal articles
  • Table of Cases
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...190, 309 Alexion Pharmaceuticals Inc v Canada (Attorney General), 2021 FCA 157 ............................................................173, 290, 295, 303, 305 Amgen Canada Inc v Apotex Inc, 2016 FCA 196 ..............................................228 Apotex v Canada (Minister of Hea......
  • Patented Medicine Prices Review Board
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...v Galderma Canada Inc , 2019 FCA 196 at para 10 [ Canada (AG) v Galderma ]. 14 Alexion Pharmaceuticals Inc v Canada (Attorney General) , 2021 FCA 157 at para 49 [ Alexion 2021 FCA ]. 15 Innovative Medicines Canada v Canada (Attorney General) , 2022 FCA 210 at para 19 [ Innovative Medicines ......
  • Overview of Canada's Pharmaceutical Intellectual Property Regime
    • Canada
    • Irwin Books The Regulation of Drugs in Canada. The Food and Drugs act and Related Intellectual Property Regimes - 2024 Part II
    • December 22, 2023
    ...(Chapter 15), the CSP regime (Chapter 16), and the PMPRB (Chapter 17). 18 Alexion Pharmaceuticals Inc v Canada (Attorney General) , 2021 FCA 157 at para 49; Innovative Medicines Canada v Canada (Attorney General) , 2022 FCA 210 at para 19. ed with patent issues. Indeed, Parliament’s policy ......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT